Patients' educational needs about topical treatments for psoriasis

Journal of the American Academy of Dermatology

Volumn 68, Issue 6, 2013, Pages

  Martin, Sabrina L ^a   McGoey, Suzanne T ^b   Bebo Jr , Bruce F ^c   Feldman, Steven R ^d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c National Psoriasis Foundation   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

corticosteroid phobia; medication adherence; patient information; webcast

Indexed keywords

STEROID; TOPICAL AGENT;

ARTICLE; DRUG COST; DRUG EFFICACY; HUMAN; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; PSORIASIS; STEROID THERAPY; TOPICAL TREATMENT;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; HUMANS; MEDICATION ADHERENCE; NEEDS ASSESSMENT; PATIENT EDUCATION AS TOPIC; PILOT PROJECTS; PSORIASIS; WEBCASTS AS TOPIC;

EID: 84877826576     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.04.016     Document Type: Article

References (30)

1. A. Menter, N.J. Korman, C.A. Elmets, S.R. Feldman, J.M. Gelfand, and K.B. Gordon Guidelines of care for the management of psoriasis and psoriatic arthritis, section 3: guidelines of care for the management and treatment of psoriasis with topical therapies J Am Acad Dermatol 60 2009 643 659
2. G. Krueger, J. Koo, M. Lebwohl, A. Menter, R.S. Stern, and T. Rolstad The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey Arch Dermatol 137 2001 280 284
3. P.C. van de Kerkhof, R.P. Steegers-Theunissen, and M.V. Kuipers Evaluation of topical drug treatment in psoriasis Dermatology 197 1998 31 36
4. A.M. Eghlileb, E.E. Davies, and A.Y. Finlay Psoriasis has a major secondary impact on the lives of family members and partners Br J Dermatol 156 2007 1245 1250
5. S.R. Rapp, S.R. Feldman, M.L. Exum, A.B. Fleischer Jr., and D.M. Reboussin Psoriasis causes as much disability as other major medical diseases J Am Acad Dermatol 41 1999 401 407
6. H.L. Richards, D.G. Fortune, and C.E. Griffiths Adherence to treatment in patients with psoriasis J Eur Acad Dermatol Venereol 20 2006 370 379
7. A. Storm, S.E. Andersen, E. Benfeldt, and J. Serup One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic J Am Acad Dermatol 59 2008 27 33
8. C.L. Carroll, S.R. Feldman, F.T. Camacho, J.C. Manuel, and R. Balkrishnan Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use J Am Acad Dermatol 51 2004 212 216
9. A. Storm, E. Benfeldt, S.E. Andersen, and J. Serup A prospective study of patient adherence to topical treatments: 95% of patients underdose J Am Acad Dermatol 59 2008 975 980
10. K.K. Brown, W.E. Rehmus, and A.B. Kimball Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis J Am Acad Dermatol 55 2006 607 613
11. T. Nijsten, T. Rolstad, S.R. Feldman, and R.S. Stern Members of the national psoriasis foundation: more extensive disease and better informed about treatment options Arch Dermatol 141 2005 19 26
12. A. Storm, E. Benfeldt, S.E. Andersen, and J. Andersen Basic drug information given by physicians is deficient, and patients' knowledge low J Dermatolog Treat 20 2009 190 193
13. E.E. Uhlenhake, D. Kurkowski, and S.R. Feldman Conversations on psoriasis-what patients want and what physicians can provide: a qualitative look at patient and physician expectations J Dermatolog Treat 21 2010 6 12
14. S.R. Feldman, E.J. Horn, R. Balkrishnan, M.K. Basra, A.Y. Finlay, and D. McCoy Psoriasis: improving adherence to topical therapy J Am Acad Dermatol 59 2008 1009 1016
15. C.L. Carroll, S.R. Feldman, F.T. Camacho, and R. Balkrishnan Better medication adherence results in greater improvement in severity of psoriasis Br J Dermatol 151 2004 895 897
16. L.C. Strowd, B.A. Yentzer, A.B. Fleischer Jr., and S.R. Feldman Increasing use of more potent treatments for psoriasis J Am Acad Dermatol 60 2009 478 481
17. C.R. Charman, A.D. Morris, and H.C. Williams Topical corticosteroid phobia in patients with atopic eczema Br J Dermatol 142 2000 931 936
18. M.A. Kinney, and S.R. Feldman What's new in the management of psoriasis? G Ital Dermatol Venereol 144 2009 103 117
19. A. Bewley Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids Br J Dermatol 158 2008 917 920
20. P.C. van de Kerkhof, D. de Hoop, J. de Korte, S.A. Cobelens, and M.V. Kuipers Patient compliance and disease management in the treatment of psoriasis in The Netherlands Dermatology 200 2000 292 298
21. S.N. Al-Suwaidan, and S.R. Feldman Clearance is not a realistic expectation of psoriasis treatment J Am Acad Dermatol 42 2000 796 802
22. M.J. Zirwas, and J.L. Holder Patient education strategies in dermatology, part 1: benefits and challenges J Clin Aesthet Dermatol 2 2009 24 27
23. M.J. Zirwas, and J.L. Holder Patient education strategies in dermatology, part 2: methods J Clin Aesthet Dermatol 2 2009 28 34
24. W. Levinson, C.S. Lesser, and R.M. Epstein Developing physician communication skills for patient-centered care Health Aff (Millwood) 29 2010 1310 1318
25. S.M. Ali, R.T. Brodell, R. Balkrishnan, and S.R. Feldman Poor adherence to treatments: a fundamental principle of dermatology Arch Dermatol 143 2007 912 915
26. A. Menter, W. Abramovits, L.E. Colon, L.A. Johnson, and R.W. Gottschalk Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis J Drugs Dermatol 8 2009 52 57
27. A.R. Mason, J. Mason, M. Cork, G. Dooley, and G. Edwards Topical treatments for chronic plaque psoriasis Cochrane Database Syst Rev 2 2009 CD005028
28. M. Lebwohl, P.T. Ting, and J.Y. Koo Psoriasis treatment: traditional therapy Ann Rheum Dis 64 Suppl 2005 ii83 ii86
29. G. Murphy, and K. Reich In touch with psoriasis: topical treatments and current guidelines J Eur Acad Dermatol Venereol 25 Suppl 2011 3 8
30. R.B. Stoughton, and K. Wullich The same glucocorticoid in brand-name products: does increasing the concentration result in greater topical biologic activity? Arch Dermatol 125 1989 1509 1511